MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
MMED Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
MiniMed Group, Inc. Common StockNASDAQ: MMED
Free Cash Flow · Q1 FY2026 · quarter ended Jul 2026
Free cash flow of -$90M in Q1 FY2026
Q1 FY2026 free cash flow was -$90M. Trailing-twelve-month free cash flow was -$316M. Over 3 fiscal years it compounded at +34.4% a year.
Context
- Free cash flow amounted to 13.5% of revenue in FY2025, up 11.6 pp from a year earlier.
- Free cash flow grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly free cash flow holds near -$90M or moves back toward the trailing-twelve-month quarterly average of -$79M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (420M) USD
- Year-over-year change
- -692.5%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2026-04-24 | (420M) | -692.5% |
| FY2024 | 2025-04-30 | (53M) | +50.5% |
| FY2023 | 2024-04-30 | (107M) | +38.2% |
| FY2022 | 2023-04-30 | (173M) | — |
Free Cash Flow vs competitors
How MMED compares with its peers on the latest reported figures
- MMED's LTM Jul 2026 free cash flow of $316M is the 3rd largest of the 7 companies compared; the peer median is $147.33M.
- Free cash flow amounts to 9.8% of revenue for MMED, versus a peer median of 22.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $6.13B | +15.6% | +5.8% | 16.3% | |
| LTM Jun 2026 | $1.41B | +146.1% | +52.3% | 28.3% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $316M | — | +34.4% | 9.8% |
| LTM Jun 2026 | $298.3M | -23.2% | — | 9.8% | |
| LTM Mar 2026 | $75.87M | +29.4% | -3.3% | 186.4% | |
| LTM Mar 2026 | $61.12M | +2.9% | -2.7% | 55.4% | |
| LTM Mar 2026 | $3.64M | -4.1% | — | 0.4% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding MMED) | $147.33M | +9.2% | +1.6% | 22.3% | |
Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Net Income | (92M) | (107M) | (198M) | (317M) |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| Deferred Income Tax | (11M) | 3M | (2M) | (54M) |
| Stock-Based Compensation | 35M | 38M | 41M | 46M |
| Change in Working Capital | (90M) | (74M) | 122M | (166M) |
| Accounts Receivables | (70M) | (105M) | (66M) | (538M) |
| Inventory | (28M) | 5M | (19M) | (29M) |
| Accounts Payables | 14M | (4M) | 191M | 41M |
| Other Working Capital | (6M) | 30M | 16M | 360M |
| Other Non-Cash Items | 37M | 52M | 34M | 138M |
| Operating Cash Flow | (6M) | 41M | 140M | (197M) |
| Capital Expenditures | (167M) | (148M) | (193M) | (223M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (13M) | (5M) | 0 | 0 |
| Sales of Investments | 0 | 11M | 0 | 0 |
| Other Investing Activities | 0 | (15M) | 0 | (10M) |
| Investing Cash Flow | (180M) | (157M) | (193M) | (233M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 538M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 185M | 112M | 10M | 178M |
| Financing Cash Flow | 185M | 112M | 10M | 716M |
| Effect of Forex Changes | 0 | 0 | 0 | 1M |
| Net Change in Cash | (2M) | (4M) | (43M) | 287M |
| Free Cash Flow | (173M) | (107M) | (53M) | (420M) |
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
Intrinsic Alpha fair value
Locked
Current Price
$16.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.